Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting
Top Cited Papers
Open Access
- 15 September 2006
- journal article
- Published by American Society of Hematology in Blood
- Vol. 108 (6), 2114-2120
- https://doi.org/10.1182/blood-2005-11-011650
Abstract
Mesenchymal stem cells (MSCs) are multipotent progenitor cells that have emerged as a promising tool for clinical application. Further clinical interKeywords
This publication has 34 references indexed in Scilit:
- Allogeneic marrow stromal cells are immune rejected by MHC class I– and class II–mismatched recipient miceBlood, 2005
- Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cellsBlood, 2005
- Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase–mediated tryptophan degradationBlood, 2004
- Effects of Mesenchymal Stem Cells on Differentiation, Maturation, and Function of Human Monocyte-Derived Dendritic CellsStem Cells and Development, 2004
- Xenoreactivity and engraftment of human mesenchymal stem cells transplanted into infarcted rat myocardiumThe Journal of Thoracic and Cardiovascular Surgery, 2004
- Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potentialBlood, 2004
- Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cellsTransplantation, 2003
- Migration of mesenchymal stem cells to heart allografts during chronic rejectionTransplantation, 2003
- Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantationTransplantation, 2003
- Multilineage Potential of Adult Human Mesenchymal Stem CellsScience, 1999